I. Douglas

First name
I.
Middle name
J.
Last name
Douglas
Tazare, J., Smeeth, L., Evans, S. J. W., Williamson, E., & Douglas, I. J. (2020). Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5121
View
Bidulka, P., Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., et al. (2020). Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study. Wellcome Open Res. http://doi.org/10.12688/wellcomeopenres.15873.1
View
Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., et al. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
View
Walker, J. L., Grint, D. J., Strongman, H., Eggo, R. M., Peppa, M., Minassian, C., et al. (2021). UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health. http://doi.org/10.1186/s12889-021-10427-2
View
Bidulka, P., O\textquoterightNeill, S., Basu, A., Wilkinson, S., Silverwood, R. J., Charlton, P., et al. (2021). Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-046912
View
Powell, E. M., Douglas, I. J., Gungabissoon, U., Smeeth, L., & Wing, K. (2021). Real-world effects of medications for stroke prevention in atrial fibrillation: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results. BMJ Open. http://doi.org/10.1136/bmjopen-2020-042947
View
Brown, J. P., Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., et al. (2021). Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14728
View